[1]
“The Correlation Between the Serum Serglycin Level and the Burden of Coronary Artery Disease in Subjects with Non-St-Elevation Myocardial Infarction”, ccm, vol. 4, no. 2, pp. 118–129, Apr. 2020, Accessed: Sep. 17, 2026. Available: https://fortunejournals.org/ojs/index.php/ccm/article/view/15809